Goefibro-M 25 Tablet
Prescription Required
Product introduction
Goefibro-M 25 Tablet is an anti-progestational steroid class of drug used for medical termination of pregnancy. It works by blocking the action of progesterone, an essential hormone for the development of pregnancy.
Goefibro-M 25 Tablet is given alone or in combination with some other medicine to attain the maximum benefit. It should be taken with food or as your doctor's advice. It should be taken orally, by swallow the tablets whole with a glass of water. If you experience vomiting within 45 minutes of tablet intake, inform your doctor or take another tablet. The medicine may take 24- 48 hours to show its action and you experience bleeding.
The most common side effects of this medicine include nausea, vomiting, uterine cramps, diarrhea, infection following abortion, and uterine bleeding. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. If you experience heavy vaginal bleeding or abdominal pain on taking this medicine, you should inform your doctor immediately.
Before taking this medicine, tell your doctor if you have ever had an ectopic pregnancy, or you are breastfeeding or using an intrauterine device. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. You must avoid strenuous activity like heavy exercise, running, and driving while abortion as it can affect the bleeding. Your doctor may perform an ultrasound or pelvic examination to check for abortion completion.
Goefibro-M 25 Tablet is given alone or in combination with some other medicine to attain the maximum benefit. It should be taken with food or as your doctor's advice. It should be taken orally, by swallow the tablets whole with a glass of water. If you experience vomiting within 45 minutes of tablet intake, inform your doctor or take another tablet. The medicine may take 24- 48 hours to show its action and you experience bleeding.
The most common side effects of this medicine include nausea, vomiting, uterine cramps, diarrhea, infection following abortion, and uterine bleeding. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. If you experience heavy vaginal bleeding or abdominal pain on taking this medicine, you should inform your doctor immediately.
Before taking this medicine, tell your doctor if you have ever had an ectopic pregnancy, or you are breastfeeding or using an intrauterine device. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. You must avoid strenuous activity like heavy exercise, running, and driving while abortion as it can affect the bleeding. Your doctor may perform an ultrasound or pelvic examination to check for abortion completion.
Uses of Goefibro-M Tablet
Side effects of Goefibro-M Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Goefibro-M
- Nausea
- Vomiting
- Uterine cramps
- Diarrhea
- Infection following abortion
- Uterine bleeding
How to use Goefibro-M Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Goefibro-M 25 Tablet is to be taken with food.
How Goefibro-M Tablet works
Goefibro-M 25 Tablet blocks the effects of progesterone, a natural female hormone which is needed for the pregnancy to sustain. Without this hormone, the lining of the uterus (womb) breaks down as it does during a menstrual period and stops the growth of the pregnancy.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Goefibro-M 25 Tablet.
Pregnancy
UNSAFE
Goefibro-M 25 Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Breast feeding
CONSULT YOUR DOCTOR
Goefibro-M 25 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Goefibro-M 25 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Goefibro-M 25 Tablet in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Goefibro-M 25 Tablet in patients with liver disease. Please consult your doctor.
What if you forget to take Goefibro-M Tablet?
If you miss a dose of Goefibro-M 25 Tablet, please consult your doctor.\n
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Goefibro-M 25 Tablet
₹53.1/Tablet
Fibroease 25mg Tablet
Akumentis Healthcare Ltd
₹74.2/tablet
40% costlier
Fibristone 25 Tablet
Jagsonpal Pharmaceuticals Ltd
₹63.8/tablet
20% costlier
Mifeone 25mg Tablet
Pharmanova India Drugs Pvt Ltd
₹60.79/tablet
14% costlier
Minifibro 25mg Tablet
Akumentis Healthcare Ltd
₹55.8/tablet
5% costlier
Fibrosure Tablet
Celagenex Research (india) Pvt Ltd
₹47.9/tablet
10% cheaper
Quick tips
- Goefibro-M 25 Tablet helps in medical termination of pregnancy.
- If you vomit within 45 minutes of taking the tablet, talk to your doctor immediately. You will need to take another tablet.
- Take it only as prescribed by the doctor. Miscarriages, if incomplete, may result in serious medical complications leading to hospitalization, surgery and possible infertility.
- Be cautious while driving or doing anything that requires concentration as it can cause dizziness and sleepiness.
- It does not affect fertility. Use contraception to avoid pregnancy.
- Take it no later than 63 days after the first day of your last menstrual period.
- Vaginal bleeding may or may not occur after taking this medicine. Inform your doctor immediately if excessive bleeding occurs or if you suffer from severe abdominal pain.
- Goefibro-M 25 Tablet helps in medical termination of pregnancy.
- Take it no later than 49 days (7 weeks) after the first day of your last menstrual period.
- If you vomit within 45 minutes of taking the tablet, talk to your doctor immediately. You will need to take another tablet.
- Take it only as prescribed by the doctor. Miscarriages, if incomplete, may result in serious medical complications leading to hospitalization, surgery and possible infertility.
- Vaginal bleeding lasting for approximately 12 days will occur after taking this medicine. Inform your doctor immediately if excessive bleeding occurs or if you suffer from severe abdominal pain.
- Be cautious while driving or doing anything that requires concentration as it can cause dizziness and sleepiness.
- It does not affect fertility. Use contraception to avoid pregnancy.
Fact Box
Chemical Class
Oxosteroid
Habit Forming
No
Therapeutic Class
GYNAECOLOGICAL
Action Class
Antiprogestins
Interaction with drugs
Taking Goefibro-M with any of the following medicines can modify the effect of either of them and cause some undesirable side effects
Dexibuprofen may reduce the efficacy of Mifepristone.
Do not consume Mifepristone with Dexibuprofen.
Mifepristone may reduce efficacy of Fosfestrol.
In case of Cushing's syndrome, your doctor may recommend you to use non-hormonal forms of contraception like, condoms during treatm
Mifepristone may raise blood levels of Acalabrutinib.
Do not consume Mifepristone with Acalabrutinib. If concurrent use is essential, watch out for symptoms such as weight gain, d
Mifepristone may reduce efficacy of Allylestrenol.
In case of Cushing's syndrome, your doctor may recommend you to use non-hormonal forms of contraception like, condoms during tre
Rifampicin may reduce blood levels of Mifepristone.
Do not consume Mifepristone with Rifampicin. If concurrent use is essential, please consult your doctor.
Patient concerns
User feedback
Patients taking Goefibro-M 25 Tablet
Once A Day
88%
Alternate Day
12%
What are you using Goefibro-M Tablet for?
Others
100%
How much was the improvement?
Excellent
67%
Average
33%
What were the side-effects while using Goefibro-M 25 Tablet?
No Side Effec*
100%
*No Side Effect
How do you take Goefibro-M Tablet?
With or witho*
100%
*With or without food
Please rate Goefibro-M 25 Tablet on price
Expensive
67%
Average
33%
FAQs
What is Goefibro-M 25 Tablet and what it is used for?
Goefibro-M 25 Tablet contains a medicine called Mifepristone. It helps in medical termination of the pregnancy. It works by blocking the effect of progesterone (a female sex hormone) which is required for maintenance of pregnancy. It is only used to terminate a pregnancy which should not be more than 63 days old, counting from the first day of the last menstrual period.
How and in what dose should I use Goefibro-M 25 Tablet?
Goefibro-M 25 Tablet can be taken orally with a glass of water. It should be taken under the supervision of a doctor.
What should I expect after taking Goefibro-M 25 Tablet?
You may or may not experience vaginal bleeding or spotting after taking this medicine. After 48 hours of taking Goefibro-M 25 Tablet, your doctor shall examine you and may prescribe you another medicine (Misoprostol) for complete termination of pregnancy. After 14 days of taking Goefibro-M 25 Tablet, your gynaecologist may run some blood tests or perform ultrasonography to confirm whether the pregnancy has been terminated or not.
Can Goefibro-M 25 Tablet affect my future chances of getting pregnant?
No, studies have shown that this medicine does not impair the fertility of the women. Your future chances of getting pregnant are as equal as of those who have not taken this medicine.
What are the common side effects of taking Goefibro-M 25 Tablet?
Vaginal bleeding and abdominal cramping are the most common side effects of using Goefibro-M 25 Tablet. The other common side effects include diarrhea, nausea, and vomiting. If you experience a very heavy vaginal bleeding or if any of these side effects bother you please consult with your gynaecologist.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Levin ER, Hammes SR. Estrogens and Progestins. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1184-85.
- Masters SB. Hypothalmic & Pituitary Hormones. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 716-17.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 916-19.
- Drugs.com. Mifepristone. [Accessed 03 Apr. 2019] (online) Available from:
- Mifepristone. Menlo Park, California: Corcept Therapeutics Incorporated; 2000. [Accessed 03 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from:
Marketer details
Name: Koye Pharmaceuticals Pvt ltd
Address: A-10, 3rd Floor, Art Guild House, Phoenix Market City Annexe, LBS Marg, Kurla (West), Mumbai - 400070
Country of origin: India
Lab tests offered by us
Related/Popular tests
NOT FOR SALE
We do not facilitate sale of this product at present